A detailed history of Compass Capital Management, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Compass Capital Management, Inc holds 368,411 shares of JNJ stock, worth $53.4 Million. This represents 3.98% of its overall portfolio holdings.

Number of Shares
368,411
Previous 370,993 0.7%
Holding current value
$53.4 Million
Previous $54.2 Million 10.11%
% of portfolio
3.98%
Previous 3.66%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$145.48 - $167.38 $375,629 - $432,175
-2,582 Reduced 0.7%
368,411 $59.7 Million
Q2 2024

Jul 25, 2024

BUY
$144.38 - $157.78 $2.55 Million - $2.78 Million
17,648 Added 4.99%
370,993 $54.2 Million
Q1 2024

Apr 29, 2024

BUY
$155.22 - $162.74 $6.66 Million - $6.98 Million
42,888 Added 13.81%
353,345 $55.9 Million
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $1.68 Million - $1.83 Million
11,531 Added 3.86%
310,457 $48.7 Million
Q3 2023

Oct 27, 2023

SELL
$155.75 - $174.48 $1.64 Million - $1.84 Million
-10,520 Reduced 3.4%
298,926 $46.6 Million
Q2 2023

Jul 31, 2023

BUY
$154.35 - $166.11 $1.78 Million - $1.92 Million
11,556 Added 3.88%
309,446 $51.2 Million
Q1 2023

May 01, 2023

BUY
$151.05 - $180.26 $1.25 Million - $1.49 Million
8,244 Added 2.85%
297,890 $46.2 Million
Q4 2022

Jan 27, 2023

SELL
$160.2 - $179.79 $1.77 Million - $1.99 Million
-11,045 Reduced 3.67%
289,646 $51.2 Million
Q3 2022

Oct 26, 2022

BUY
$161.33 - $179.52 $894,252 - $995,079
5,543 Added 1.88%
300,691 $49.1 Million
Q2 2022

Jul 27, 2022

SELL
$168.19 - $186.01 $4.79 Million - $5.29 Million
-28,459 Reduced 8.79%
295,148 $52.4 Million
Q1 2022

May 06, 2022

BUY
$158.14 - $179.59 $705,936 - $801,689
4,464 Added 1.4%
323,607 $57.4 Million
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $2.24 Million - $2.49 Million
14,391 Added 4.72%
319,143 $54.6 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $482,885 - $536,615
2,990 Added 0.99%
304,752 $49.2 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $2.89 Million - $3.1 Million
18,145 Added 6.4%
301,762 $49.7 Million
Q1 2021

Apr 29, 2021

BUY
$153.07 - $170.48 $373,184 - $415,630
2,438 Added 0.87%
283,617 $46.6 Million
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $3.28 Million - $3.76 Million
23,913 Added 9.3%
281,179 $44.3 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $1.45 Million - $1.59 Million
10,326 Added 4.18%
257,266 $38.3 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $365,305 - $441,026
-2,836 Reduced 1.14%
246,940 $34.7 Million
Q1 2020

Apr 24, 2020

SELL
$111.14 - $153.99 $595,599 - $825,232
-5,359 Reduced 2.1%
249,776 $32.8 Million
Q4 2019

Jan 30, 2020

BUY
$127.5 - $146.44 $1.44 Million - $1.66 Million
11,311 Added 4.64%
255,135 $37.2 Million
Q3 2019

Oct 22, 2019

BUY
$126.95 - $142.14 $2.31 Million - $2.58 Million
18,166 Added 8.05%
243,824 $31.5 Million
Q2 2019

Jul 31, 2019

BUY
$131.15 - $144.24 $970,510 - $1.07 Million
7,400 Added 3.39%
225,658 $31.4 Million
Q1 2019

May 06, 2019

BUY
$125.72 - $139.79 $675,996 - $751,650
5,377 Added 2.53%
218,258 $30.5 Million
Q4 2018

Jan 28, 2019

BUY
$122.84 - $147.84 $143,722 - $172,972
1,170 Added 0.55%
212,881 $27.5 Million
Q3 2018

Oct 31, 2018

BUY
$121.58 - $142.88 $199,999 - $235,037
1,645 Added 0.78%
211,711 $29.3 Million
Q2 2018

Jul 20, 2018

BUY
$119.4 - $131.76 $1.45 Million - $1.6 Million
12,119 Added 6.12%
210,066 $25.5 Million
Q1 2018

Apr 27, 2018

BUY
$125.1 - $148.14 $1.05 Million - $1.24 Million
8,357 Added 4.41%
197,947 $25.4 Million
Q4 2017

Jan 30, 2018

BUY
$131.22 - $143.62 $536,821 - $587,549
4,091 Added 2.21%
189,590 $26.5 Million
Q3 2017

Nov 01, 2017

BUY
$129.47 - $135.38 $24 Million - $25.1 Million
185,499
185,499 $24.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Compass Capital Management, Inc Portfolio

Follow Compass Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Compass Capital Management, Inc with notifications on news.